DE1618853B2 - 21-trialkylsiloxypregna-3,20-dione und verfahren zu deren herstellung - Google Patents
21-trialkylsiloxypregna-3,20-dione und verfahren zu deren herstellungInfo
- Publication number
- DE1618853B2 DE1618853B2 DE1967S0108328 DES0108328A DE1618853B2 DE 1618853 B2 DE1618853 B2 DE 1618853B2 DE 1967S0108328 DE1967S0108328 DE 1967S0108328 DE S0108328 A DES0108328 A DE S0108328A DE 1618853 B2 DE1618853 B2 DE 1618853B2
- Authority
- DE
- Germany
- Prior art keywords
- parts
- dione
- methyl
- fluoro
- trialkylsiloxypregna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- -1 alkyl radicals Chemical class 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 4
- 150000003431 steroids Chemical class 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 10
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
- 239000005457 ice water Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000005051 trimethylchlorosilane Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- SIOVKLKJSOKLIF-UHFFFAOYSA-N bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)OC(C)=N[Si](C)(C)C SIOVKLKJSOKLIF-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000005046 Chlorosilane Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 2
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical class Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- XMRPGKVKISIQBV-UHFFFAOYSA-N (+-)-5- Pregnane-3,20-dione Natural products C1CC2CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)C1(C)CC2 XMRPGKVKISIQBV-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- USPYDUPOCUYHQL-KVHKMPIWSA-N 5alpha-dihydrodeoxycorticosterone Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CC[C@H]21 USPYDUPOCUYHQL-KVHKMPIWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- QIEPWCSVQYUPIY-LEKSSAKUSA-N Delta(1)-progesterone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 QIEPWCSVQYUPIY-LEKSSAKUSA-N 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229910014299 N-Si Inorganic materials 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001098 anti-algal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52841066A | 1966-02-18 | 1966-02-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE1618853A1 DE1618853A1 (de) | 1971-02-25 |
| DE1618853B2 true DE1618853B2 (de) | 1976-11-18 |
Family
ID=24105578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1967S0108328 Granted DE1618853B2 (de) | 1966-02-18 | 1967-02-15 | 21-trialkylsiloxypregna-3,20-dione und verfahren zu deren herstellung |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE694135A (enrdf_load_stackoverflow) |
| CH (1) | CH507297A (enrdf_load_stackoverflow) |
| DE (1) | DE1618853B2 (enrdf_load_stackoverflow) |
| DK (1) | DK117897B (enrdf_load_stackoverflow) |
| FR (1) | FR6117M (enrdf_load_stackoverflow) |
| GB (1) | GB1135560A (enrdf_load_stackoverflow) |
| GR (1) | GR36782B (enrdf_load_stackoverflow) |
| IL (1) | IL27448A (enrdf_load_stackoverflow) |
| SE (1) | SE331094B (enrdf_load_stackoverflow) |
-
1967
- 1967-01-30 GB GB749167A patent/GB1135560A/en not_active Expired
- 1967-02-14 DK DK80067A patent/DK117897B/da unknown
- 1967-02-15 DE DE1967S0108328 patent/DE1618853B2/de active Granted
- 1967-02-16 BE BE694135D patent/BE694135A/xx unknown
- 1967-02-16 IL IL2744867A patent/IL27448A/xx unknown
- 1967-02-17 CH CH234667A patent/CH507297A/de not_active IP Right Cessation
- 1967-02-17 FR FR95483A patent/FR6117M/fr not_active Expired
- 1967-02-17 GR GR670136782A patent/GR36782B/el unknown
- 1967-02-17 SE SE222167A patent/SE331094B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE694135A (enrdf_load_stackoverflow) | 1967-08-16 |
| SE331094B (enrdf_load_stackoverflow) | 1970-12-14 |
| GB1135560A (en) | 1968-12-04 |
| DE1618853A1 (de) | 1971-02-25 |
| IL27448A (en) | 1971-01-28 |
| FR6117M (enrdf_load_stackoverflow) | 1968-06-17 |
| CH507297A (de) | 1971-05-15 |
| DK117897B (da) | 1970-06-15 |
| GR36782B (el) | 1969-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1493080A1 (de) | Spiro-(steroid-6,1'-cyclopropane) und Verfahren zu deren Herstellung | |
| DE3005736A1 (de) | Vitamin d tief 3 -derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe | |
| EP0110041B1 (de) | Neue 6alpha-Methylkortikoide, ihre Herstellung und Verwendung | |
| EP0749438B1 (de) | Neue silylverbindungen und ihre verwendung | |
| DE3226164C2 (enrdf_load_stackoverflow) | ||
| DE2932925C2 (enrdf_load_stackoverflow) | ||
| DE1618853C3 (de) | 21-Trialkylsiloxypregna-3,20-dione und Verfahren zu deren Herstellung | |
| DE2645104C2 (de) | 11β-Hydroxy-1,4,8-pregnatrien-3,20-dion-Derivate und Verfahren zu ihrer Herstellung | |
| DE1618853B2 (de) | 21-trialkylsiloxypregna-3,20-dione und verfahren zu deren herstellung | |
| DE1768345B2 (de) | Dimere steroid-21-alkylcarbonate und verfahren zu ihrer herstellung | |
| EP0201452B1 (de) | Verfahren zur Herstellung von 17alpha-Ethinyl-17beta-hydroxy-18-methyl-4,15-estradien-3-on und die neuen Ausgangsverbindungen für dieses Verfahren | |
| DE4239946A1 (de) | Estranderivate mit einer 14alpha,15alpha-Methylengruppe und Verfahren zu ihrer Herstellung | |
| DE2551562C2 (de) | Steroide der Pregnanreihe, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| EP0023006B1 (de) | Verfahren zur Herstellung von ungesättigten Steroiden | |
| DE1668079B2 (de) | Dialkylorthocarbonate von 17alpha, 21-dihydroxysteroiden und verfahren zu ihrer herstellung | |
| EP0149222A2 (de) | Neue 6alpha, 16alpha-Dimethylkortikoide | |
| DE4120124B4 (de) | Verfahren zur Herstellung von Derivaten des Cholesterols und seiner Homologen | |
| DE3501564A1 (de) | (16,17-a)cyclopentanpregnene und diese enthaltende arzneimittel | |
| DE2655104A1 (de) | Verfahren zur herstellung von 17alpha-hydroxy-21-acetoxy-progesteron | |
| DE2137557C3 (de) | Verfahren zur Herstellung von Acyloxy Delta 4 androstenen bzw ostrenen | |
| DE4239945A1 (de) | 14 alpha, 15 alpha-Methylensteroide und Verfahren zu ihrer Herstellung | |
| DE2712862C2 (de) | Derivate des 9-Fluorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE1903118C (de) | Verfahren zur Herstellung von 17 alpha Monoestern von 11 beta, 17 alpha 21-Tnhydroxysteroiden | |
| DE2531145A1 (de) | Verfahren zur herstellung von 11beta-hydroxy-18-alkyl-steroiden der oestranreihe | |
| EP0078432A1 (de) | Neue Kortikoide, ihre Herstellung und Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C3 | Grant after two publication steps (3rd publication) | ||
| E77 | Valid patent as to the heymanns-index 1977 | ||
| EHJ | Ceased/non-payment of the annual fee |